Literature DB >> 16823377

A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice.

Minh D To1, Jesus Perez-Losada, Jian-Hua Mao, Jeff Hsu, Tyler Jacks, Allan Balmain.   

Abstract

Pulmonary adenoma susceptibility 1 (Pas1) is the major mouse lung cancer susceptibility locus on chromosome 6 (ref. 1). Kras2 is a common target of somatic mutation in chemically induced mouse lung tumors and is a candidate Pas1 gene. M. spretus mice (SPRET/Ei) carry a Pas1 resistance haplotype for chemically induced lung tumors. We demonstrate that the SPRET/Ei Pas1 allele is switched from resistance to susceptibility by fixation of the parental origin of the mutant Kras2 allele. This switch correlates with low expression of endogenous Kras2 in SPRET/Ei. We propose that the Pas1 modifier effect is due to Kras2, and that a sensitive balance between the expression levels of wild-type and mutant alleles determines lung tumor susceptibility. These data demonstrate that cancer predisposition should also be considered in the context of somatic events and could have major implications for the design of human association studies to identify cancer susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823377      PMCID: PMC4461000          DOI: 10.1038/ng1836

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  30 in total

1.  Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'.

Authors:  Leonid Bystrykh; Ellen Weersing; Bert Dontje; Sue Sutton; Mathew T Pletcher; Tim Wiltshire; Andrew I Su; Edo Vellenga; Jintao Wang; Kenneth F Manly; Lu Lu; Elissa J Chesler; Rudi Alberts; Ritsert C Jansen; Robert W Williams; Michael P Cooke; Gerald de Haan
Journal:  Nat Genet       Date:  2005-02-13       Impact factor: 38.330

2.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors:  E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Wildtype Kras2 can inhibit lung carcinogenesis in mice.

Authors:  Z Zhang; Y Wang; H G Vikis; L Johnson; G Liu; J Li; M W Anderson; R C Sills; H L Hong; T R Devereux; T Jacks; K L Guan; M You
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Genetics of gene expression surveyed in maize, mouse and man.

Authors:  Eric E Schadt; Stephanie A Monks; Thomas A Drake; Aldons J Lusis; Nam Che; Veronica Colinayo; Thomas G Ruff; Stephen B Milligan; John R Lamb; Guy Cavet; Peter S Linsley; Mao Mao; Roland B Stoughton; Stephen H Friend
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

5.  A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6.

Authors:  M Gariboldi; G Manenti; F Canzian; F S Falvella; M T Radice; M A Pierotti; G Della Porta; G Binelli; T A Dragani
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

6.  Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.

Authors:  M You; Y Wang; G Stoner; L You; R Maronpot; S H Reynolds; M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  Mutagenesis of the K-ras protooncogene in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine.

Authors:  M You; Y Wang; A M Lineen; W T Gunning; G D Stoner; M W Anderson
Journal:  Carcinogenesis       Date:  1992-09       Impact factor: 4.944

8.  Pulmonary adenoma susceptibility 1 (Pas1) locus affects inflammatory response.

Authors:  Durvanei Augusto Maria; Giacomo Manenti; Federica Galbiati; Orlando Garcia Ribeiro; Wafa Hanna Koury Cabrera; Roberto Giannì Barrera; Angela Pettinicchio; Marcelo De Franco; Nancy Starobinas; Maria Siqueira; Tommaso A Dragani; Olga Martinez Ibañez
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

9.  Distinct genetic loci control development of benign and malignant skin tumours in mice.

Authors:  H Nagase; S Bryson; H Cordell; C J Kemp; F Fee; A Balmain
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

10.  Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.

Authors:  M You; U Candrian; R R Maronpot; G D Stoner; M W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more
  29 in total

1.  Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer.

Authors:  Craig M Bielski; Mark T A Donoghue; Mayur Gadiya; Aphrothiti J Hanrahan; Helen H Won; Matthew T Chang; Philip Jonsson; Alexander V Penson; Alexander Gorelick; Christopher Harris; Alison M Schram; Aijazuddin Syed; Ahmet Zehir; Paul B Chapman; David M Hyman; David B Solit; Kevin Shannon; Sarat Chandarlapaty; Michael F Berger; Barry S Taylor
Journal:  Cancer Cell       Date:  2018-11-01       Impact factor: 31.743

Review 2.  Systems genetics analysis of cancer susceptibility: from mouse models to humans.

Authors:  David Quigley; Allan Balmain
Journal:  Nat Rev Genet       Date:  2009-07-28       Impact factor: 53.242

3.  Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer.

Authors:  Eric J Duell; Paige M Bracci; Jason H Moore; Robert D Burk; Karl T Kelsey; Elizabeth A Holly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

Review 4.  Cancer evolution and individual susceptibility.

Authors:  Jesús Pérez-Losada; Andrés Castellanos-Martín; Jian-Hua Mao
Journal:  Integr Biol (Camb)       Date:  2011-01-24       Impact factor: 2.192

5.  KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.

Authors:  Michael R Burgess; Eugene Hwang; Rana Mroue; Craig M Bielski; Anica M Wandler; Benjamin J Huang; Ari J Firestone; Amy Young; Jennifer A Lacap; Lisa Crocker; Saurabh Asthana; Elizabeth M Davis; Jin Xu; Keiko Akagi; Michelle M Le Beau; Qing Li; Benjamin Haley; David Stokoe; Deepak Sampath; Barry S Taylor; Marie Evangelista; Kevin Shannon
Journal:  Cell       Date:  2017-02-16       Impact factor: 41.582

6.  Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer.

Authors:  Minh D To; David A Quigley; Jian-Hua Mao; Reyno Del Rosario; Jeff Hsu; Graeme Hodgson; Tyler Jacks; Allan Balmain
Journal:  Mol Cancer Res       Date:  2011-08-01       Impact factor: 5.852

7.  Rare codons capacitate Kras-driven de novo tumorigenesis.

Authors:  Nicole L K Pershing; Benjamin L Lampson; Jason A Belsky; Erin Kaltenbrun; David M MacAlpine; Christopher M Counter
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

Review 8.  The Kras2 oncogene and mouse lung carcinogenesis.

Authors:  Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

9.  Modeling cancer patient populations in mice: complex genetic and environmental factors.

Authors:  Daniel R Radiloff; Erica S Rinella; David W Threadgill
Journal:  Drug Discov Today Dis Models       Date:  2008

10.  Sequence divergence of Mus spretus and Mus musculus across a skin cancer susceptibility locus.

Authors:  Kimberly L Mahler; Jessica L Fleming; Amy M Dworkin; Nicholas Gladman; Hee-Yeon Cho; Jian-Hua Mao; Allan Balmain; Amanda Ewart Toland
Journal:  BMC Genomics       Date:  2008-12-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.